Adial Pharmaceuticals agrees to merge with Azora Therapeutics
Adial Pharmaceuticals signed a merger agreement with Azora Therapeutics, effective June 11, 2026, combining the two pharmaceutical companies. The transaction involves a two-step merger structure with detailed terms for share conversion and consideration exchange.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day